跳至主要内容
临床试验/NCT01516034
NCT01516034终止不适用

The Efficacy of the Cupola Ultrasonic Tattoo Removal Device: A Prospective Single Blinded, Before-After Study Design

Cupola Medical Ltd1 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2011年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
8
试验地点
1
主要终点
Tattoo Removal Efficiency

研究概览

简要总结

The study is designed to determine the efficacy of the Cupola tattoo removal device for tattoo removal.

详细描述

The Cupola system is a non-invasive device for pigment/tattoo removal based on ultrasound technology. The safety of the device was demonstrated in a previous pilot study approved by the Herzog Helsinki committee #167-09, Ministry of Health April 2010 #HT-5293) showing that no risk was associated with the procedure.

This study is designed to determine the efficacy of the device for tattoo removal in up to 6 treatments in different treatment intervals. Three areas of the tattoo that are similar in size, color, and intensity will be chosen. One area will not be treated; the second will receive 6 treatments in 2-3 week intervals; the third will receive 3 treatments in 4-6 week intervals. The evaluations will include color measurements, photography, subject comfort and skin condition.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age of tattoo - more than 1 year since application
  • Type - decorative (not cosmetic)
  • Not previously treated
  • At least 18 years of age
  • Agrees to sign the Informed Consent
  • Willingness to remove tattoo
  • Willingness to have photographs and color measurements of the treated area taken and to be used for marketing and educational presentation and/or publications
  • Willingness to follow the treatment schedule and post treatment care requirement for tattooing and removal
  • Not planning to remove the tattoo in a different procedure during the time of the experiment

排除标准

  • Skin conditions
  • Skin type 5 and 6
  • History of keloid formation
  • Active herpes simplex
  • Psoriasis or vitiligo
  • Other medical conditions
  • HIV or Hepatitis
  • Pregnancy or intention to become pregnant in the next 6 months
  • No allergic reaction during the tattooing process.
  • Currently taking anticoagulant medication, blood thinners, steroids or immunosuppressive
  • Taking isotretinoin (Accutane) currently or within the last 6 months
  • Minocyclin

结局指标

主要结局

Tattoo Removal Efficiency

时间窗: 6 months (termination)

Extent of Tattoo removal is quantified in 2 methods based on photographs taken at the baseline visit and at the termination visit: 1. Scoring by independent dermatologist 2. Measuring pigment clearance using image analysis

次要结局

  • Tolerability Score(0, 2, 4, 6, 8, 10 weeks (after every treatment))

研究者

发起方
Cupola Medical Ltd
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验